Table 3.
Multivariate HRa | 95% CI |
P
value |
|
---|---|---|---|
Initial age | 1.04 | 1.03–1.04 | .04 |
Gender | |||
Female | Reference | ||
Male | 0.74 | 0.58–0.95 | .02 |
Ethnicity | |||
White | Reference | ||
Black | 0.69 | 0.46–1.04 | .07 |
Hispanic | 1.41 | 1.15–1.74 | <.001 |
Asian | 0.62 | 0.32–1.20 | .16 |
Other | 1.49 | 0.84–2.63 | .17 |
Body mass index | 1.00 | 0.99–1.02 | .73 |
Diabetes | 1.08 | 0.87–1.35 | .49 |
Initial MELD score | 1.02 | 1.01–1.04 | <.001 |
Ascites | 1.10 | 1.01–1.18 | .22 |
Hepatic encephalopathy | |||
None | Reference | ||
Moderate | 1.09 | 0.93–1.29 | .30 |
Severe | 1.49 | 1.05–2.42 | .04 |
Portal venous thrombosis | 0.82 | .32 | |
Spontaneous bacterial | 1.13 | 0.77–1.02 | .54 |
peritonitis |
CI, confidence interval; HR, hazard ratio; MELD, Model for End-Stage Liver Disease; OPTN/UNOS, Organ Procurement Transplant Network/United Network for Organ Sharing; PBC, primary biliary cholangitis.
Additionally adjusted for OPTN/UNOS Region of listing.